Position in ERAS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,831,834
+$1,643,584 QoQ
Shares Held
113,216
+123.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. ERAS ranks #42 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,137 | $10,331,595 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,332 | $7,982,916 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,647 | $4,846,252 | |
| 4 | INSM |
INSMED Inc
|
27,937 | $4,568,258 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
81,190 | $3,266,273 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
4,862 | $2,545,111 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
76,039 | $2,526,015 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
39,758 | $2,492,826 |
All Filings in ERAS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,831,834 | 113,216 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $188,250 | 50,605 | Shares | Sole | 2026-02-06 | |
| 2024-12-31 | $107,006 | 42,632 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $130,018 | 47,626 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||